Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer, Biomarkers”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Not applicableActive Not RecruitingNCT07511517
What this trial is testing

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell, Bladder
Oslo University Hospital 500
Not applicableUnknownNCT01198808
What this trial is testing

Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker

Who this might be right for
Bladder Cancer
Technical University of Munich 50
Testing effectiveness (Phase 2)Looking for participantsNCT03379909
What this trial is testing

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

Who this might be right for
Superficial Bladder CancerBladder Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 49
Not applicableNot Yet RecruitingNCT07307300
What this trial is testing

Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test

Who this might be right for
Hematuria
Christian Bolenz 1,475
Not applicableEnded earlyNCT02900248
What this trial is testing

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Who this might be right for
NeoplasmsLung NeoplasmsColon Neoplasms+22 more
CureOne 23
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Not applicableStudy completedNCT01918592
What this trial is testing

PET/MRI and Biomarkers in Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 25
Not applicableLooking for participantsNCT06026189
What this trial is testing

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

Who this might be right for
HematuriaUrothelial NeoplasmUrothelial Carcinoma+1 more
Erasmus Medical Center 1,100
Not applicableUnknownNCT03563443
What this trial is testing

Genomic Imprinting Testing for Diagnosis of Bladder Cancer

Who this might be right for
Bladder CancerUrine MarkingDiagnoses Disease
Changhai Hospital 300
Not applicableEnded earlyNCT02027649
What this trial is testing

Detection of K14 in Bladder Cancer With a Non Invasive Technique

Who this might be right for
Bladder Cancer
Corporacion Parc Tauli 400
Testing effectiveness (Phase 2)Study completedNCT00003759
What this trial is testing

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals
Not applicableLooking for participantsNCT04442724
What this trial is testing

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Who this might be right for
Bladder CancerUrinary Bladder NeoplasmUrologic Neoplasms+2 more
Cedars-Sinai Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Not applicableLooking for participantsNCT04993859
What this trial is testing

Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Who this might be right for
Survivors of Childhood CancerBladder Dysfunction
University of Colorado, Denver 152
Not applicableStudy completedNCT00776178
What this trial is testing

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 68
Not applicableUnknownNCT05139134
What this trial is testing

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Urothelial Carcinoma
Sohag University 50
Not applicableEnded earlyNCT02053662
What this trial is testing

Biomarker Identification for Bladder Cancer Patients

Who this might be right for
Bladder Cancer
Ohio State University Comprehensive Cancer Center 179
Not applicableUnknownNCT03121768
What this trial is testing

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
OncologyBladder CancerSuperficial Bladder Cancer+3 more
Mansoura University 761
Not applicableUnknownNCT05337189
What this trial is testing

Clinical Trial of Urine DNA Testing for Bladder Cancer in China

Who this might be right for
Bladder CancerUrocystitisUrinary Bladder Stone+1 more
Creative Biosciences (Guangzhou) Co., Ltd. 482
Next Page